Identification and treatment of the vulnerable coronary plaque

被引:28
作者
van Veelen, Anna [1 ]
van der Sangen, Niels M. R. [1 ]
Henriques, Jose P. S. [1 ]
Claessen, Bimmer E. P. M. [1 ]
机构
[1] Univ Amsterdam, Amsterdam UMC, Heart Ctr, Dept Cardiol,Amsterdam Cardiovasc Sci, NL-1105 AZ Amsterdam, Netherlands
关键词
Vulnerable plaque; Atherosclerosis; Acute coronary syndrome; Intracoronary imaging; Non-invasive imaging; NEAR-INFRARED SPECTROSCOPY; OPTICAL COHERENCE TOMOGRAPHY; ACUTE MYOCARDIAL-INFARCTION; RISK-ASSESSMENT STRATEGIES; THIN-CAP FIBROATHEROMA; C-REACTIVE PROTEIN; ARTERY-DISEASE; STATIN THERAPY; ATHEROSCLEROTIC LESIONS; IN-VIVO;
D O I
10.31083/j.rcm2301039
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Acute coronary syndrome mostly arises from rupture or erosion of a vulnerable plaque. Vulnerable plaques typically appear as lipid-rich plaques with a thin cap, called thin-cap fibroatheromas. Various intracoronary imaging techniques can be used to detect vulnerable plaques, such as intravascular ultrasound (IVUS), optical coherence tomography (OCT) and near-infrared spectroscopy (NIRS), each visualizing different high-risk plaque characteristics. IVUS and its post-processing techniques, such as virtual histology IVUS, can primarily be used to identify calcified and soft plaques, while OCT is also able to quantitatively measure the cap thickness. The addition of NIRS allows the exact measurement of lipid content in the plaque. Non-invasive imaging techniques to identify vulnerable plaques, such as computed tomography, are less often used but are evolving and may be of additional diagnostic use, especially when prophylactic treatments for vulnerable plaques are further established. Pharmacological treatment with lipid-lowering or anti-inflammatory medication leads to plaque stabilization and reduction of cardiovascular events. Moreover, the implantation of a stent or scaffold for the local treatment of vulnerable plaques has been found to be safe and to stabilize high-risk plaque features. The use of drug-coated balloons to treat vulnerable plaques is the subject of ongoing research. Future studies should focus on non-invasive imaging techniques to adequately identify vulnerable plaques and further randomized clinical studies are necessary to find the most appropriate treatment strategy for vulnerable plaques.
引用
收藏
页数:15
相关论文
共 126 条
[1]  
Abbara S., 2008, YB DIAGNOSTIC RADIOL, V2009, P346
[2]  
Al-Lamee R, EUR HEART J, V42, P4680
[3]   Spectroscopic photoacoustic imaging of lipid-rich plaques in the human aorta in the 740 to 1400 nm wavelength range [J].
Allen, Thomas J. ;
Hall, Andrew ;
Dhillon, Amar P. ;
Owen, James S. ;
Beard, Paul C. .
JOURNAL OF BIOMEDICAL OPTICS, 2012, 17 (06)
[4]   ANGIOGRAPHIC PROGRESSION OF CORONARY-ARTERY DISEASE AND THE DEVELOPMENT OF MYOCARDIAL-INFARCTION [J].
AMBROSE, JA ;
TANNENBAUM, MA ;
ALEXOPOULOS, D ;
HJEMDAHLMONSEN, CE ;
LEAVY, J ;
WEISS, M ;
BORRICO, S ;
GORLIN, R ;
FUSTER, V .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1988, 12 (01) :56-62
[5]   Anatomical and Physiological Changes after Paclitaxel-Coated Balloon for Atherosclerotic De Novo Coronary Lesions: Serial IVUS-VH and FFR Study [J].
Ann, Soe Hee ;
Singh, Gillian Balbir ;
Lim, Kyung Hun ;
Koo, Bon-Kwon ;
Shin, Eun-Seok .
PLOS ONE, 2016, 11 (01)
[6]   Detecting human coronary inflammation by imaging perivascular fat [J].
Antonopoulos, Alexios S. ;
Sanna, Fabio ;
Sabharwal, Nikant ;
Thomas, Sheena ;
Oikonomou, Evangelos K. ;
Herdman, Laura ;
Margaritis, Marios ;
Shirodaria, Cheerag ;
Kampoli, Anna-Maria ;
Akoumianakis, Ioannis ;
Petrou, Mario ;
Sayeed, Rana ;
Krasopoulos, George ;
Psarros, Constantinos ;
Ciccone, Patricia ;
Brophy, Carl M. ;
Digby, Janet ;
Kelion, Andrew ;
Uberoi, Raman ;
Anthony, Suzan ;
Alexopoulos, Nikolaos ;
Tousoulis, Dimitris ;
Achenbach, Stephan ;
Neubauer, Stefan ;
Channon, Keith M. ;
Antoniades, Charalambos .
SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (398)
[7]   Thrombosis formation on atherosclerotic lesions and plaque rupture [J].
Badimon, L. ;
Vilahur, G. .
JOURNAL OF INTERNAL MEDICINE, 2014, 276 (06) :618-632
[8]   Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials [J].
Baigent, C. ;
Blackwell, L. ;
Emberson, J. ;
Holland, L. E. ;
Reith, C. ;
Bhala, N. ;
Peto, R. ;
Barnes, E. H. ;
Keech, A. ;
Simes, J. ;
Collins, R. .
LANCET, 2010, 376 (9753) :1670-1681
[9]   The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial [J].
Baigent, Colin ;
Landray, Martin J. ;
Reith, Christina ;
Emberson, Jonathan ;
Wheeler, David C. ;
Tomson, Charles ;
Wanner, Christoph ;
Krane, Vera ;
Cass, Alan ;
Craig, Jonathan ;
Neal, Bruce ;
Jiang, Lixin ;
Hooi, Lai Seong ;
Levin, Adeera ;
Agodoa, Lawrence ;
Gaziano, Mike ;
Kasiske, Bertram ;
Walker, Robert ;
Massy, Ziad A. ;
Feldt-Rasmussen, Bo ;
Krairittichai, Udom ;
Ophascharoensuk, Vuddidhej ;
Fellstrom, Bengt ;
Holdaas, Hallvard ;
Tesar, Vladimir ;
Wiecek, Andrzej ;
Grobbee, Diederick ;
de Zeeuw, Dick ;
Gronhagen-Riska, Carola ;
Dasgupta, Tanaji ;
Lewis, David ;
Herrington, William ;
Mafham, Marion ;
Majoni, William ;
Wallendszus, Karl ;
Grimm, Richard ;
Pedersen, Terje ;
Tobert, Jonathan ;
Armitage, Jane ;
Baxter, Alex ;
Bray, Christopher ;
Chen, Yiping ;
Chen, Zhengming ;
Hill, Michael ;
Knott, Carol ;
Parish, Sarah ;
Simpson, David ;
Sleight, Peter ;
Young, Alan ;
Collins, Rory .
LANCET, 2011, 377 (9784) :2181-2192
[10]   Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography - A study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden [J].
Ballantyne, Christie M. ;
Raichlen, Joel S. ;
Nicholls, Stephen J. ;
Erbel, Raimund ;
Tardif, Jean-Claude ;
Brener, Sorin J. ;
Cain, Valerie A. ;
Nissen, Steven E. .
CIRCULATION, 2008, 117 (19) :2458-2466